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DJ-1 (PARK7) was first identified as an oncogene 
that represses PTEN and thus induces proliferation in 
certain types of cancer [1]. Later, it was found that loss 
of DJ-1 leads to early onset of Parkinson’s disease, 
characterised by a loss of dopaminergic neurons in the 
midbrain [2]. Even after more than a decade of intense 
research, the exact cellular function of DJ-1 is still elusive. 
Two hallmarks of DJ-1 are scavenging of reactive oxygen 
species (ROS) and its relation to mitochondria, a hub for 
central metabolism. Even though highly proliferating 
cancer cells and post-mitotic neurons are very different 
cell types, they have a common challenge: balancing ROS, 
derived from high metabolic burden. 
In a recent study by our lab, we investigated the 
role of DJ-1 on cellular metabolism in post-mitotic human 
neurons derived from the midbrain [3]. In line with the 
common observation of increased sensitivity to ROS, we 
observed an increased GSSG (oxidised glutathione) to 
GSH (reduced glutathione) ratio and increased sensitivity 
to the ROS inducing compound 6-hydroxydopamine, 
an oxidation product of dopamine. Our results suggest 
that altered glutamine and serine metabolism might be 
the metabolic cause for the observed changes in GSH 
homeostasis. Glutathione consists of the three amino acids 
glutamate, glycine and cysteine. Glutamate is derived from 
glutamine and glycine and cysteine can be derived from 
serine by the activity of serine hydroxymethyltransferase 
(SHMT) and via the transsulfuration pathway, respectively. 
The SHMT reaction also fuels the folate mediated one-
carbon (1C) metabolism by donating carbon three of serine 
to tetrahydrofolate (THF). 5,10-methylene-THF can then 
be oxidised to formate via the folate cycle. Depending on 
the enzyme isoform and the compartment, this oxidation is 
NADP+ or NAD+ dependent, providing additional reducing 
potential to the cell [4]. While NADPH can be used to 
reduce GSSG back to GSH, NADH can be oxidised via 
oxidative phosphorylation to generate ATP. 
Our work provides a comprehensive overview 
of the effects of loss of DJ1 on central metabolism 
in non-proliferating neuronal cells and points to key 
metabolic steps that are crucial for cellular ROS 
homeostasis. However, the mechanistic link, how DJ-1 
controls glutamine and serine-1C metabolism is still 
under investigation. In cancer cells, the serine synthesis 
pathway (SSP) and cellular antioxidant responses are, 
amongst others, controlled by NRF2 that can be stabilised 
by DJ-1 [5]. However, we observed that NRF2 is in 
very low abundance in our neuronal cell model. This is 
interesting for two reasons: 1) This finding emphasises the 
importance of studying mechanistic links individually in 
different cell models and that one has to be very careful in 
drawing general conclusions based on data derived from 
one single cell model. 2) The low abundance of NRF2 in 
the neuronal cell model raises the question of how SSP, 
glutamine and 1C metabolism is regulated by DJ-1. Based 
on a previous study, together with our collaborators from 
the Leist lab we have strong evidence that such a candidate 
could be ATF4 [6]. In the latter study we investigated the 
cellular events in neuronal cells upon increased oxidative 
stress. Upon elevated, but non-apoptotic oxidative stress 
the SSP, transsulfuration pathway and 1C metabolism 
was up regulated and centrally controlled by ATF4. 
Concluding from our finding that loss of DJ-1 affects 
serine and 1C metabolism, that loss of DJ-1 makes cells 
more susceptible to oxidative stress [3] and that neuronal 
cells exposed to oxidative stress induce ATF4 to increase 
serine biosynthesis, transsulfuration and 1C metabolism 
[6], is suggestive that DJ-1 might control these metabolic 
pathways via ATF4 (Figure 1). However, this is still under 
investigation.
As we mentioned in the introduction, DJ-1 is 
associated with mitochondria. A canonical function of 
mitochondria, especially in non-proliferating cells, is the 
provision of ATP to fulfil the energy demands of these 
highly catabolic cells. Intriguingly, we demonstrated 
very recently that the function of serine mediated 1C 
metabolism is not only to fulfil anabolic demands but that 
the major fraction of serine has a catabolic role. In contrast 
with current understanding of cancer metabolism [7], we 
have demonstrated that most of the serine, which is the 
major carbon donor of 1C metabolism, is catabolised to 
glycine and formate in the mitochondria and then released 
by cells [8]. Moreover, we have demonstrated that the 
oxidation of 5,10-methylene THF is coupled to complex I 
in the mitochondria and thus coupled to ATP generation. 
In addition, the release of every formate contributes also 
with net ATP production to the cellular energy pool. These 
observations have been made in proliferating cancer and 
non-transformed, proliferating fibroblast cell lines. Based 
on our findings that DJ-1 affects serine 1C metabolism 
in non-proliferating, highly catabolic neuronal cells raises 
the question of whether DJ-1 also affects formate release 
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in neurons and if serine catabolism via the folate pathway 
might be an alternative way for energy supply in neurons. 
This notion could also explain our observed differences in 
mitochondrial motility upon DJ-1 silencing.
In summary, this work underlines the exciting but 
at the same time challenging topic surrounding the still 
elusive functions of DJ-1, a protein that apparently has 
to be at the right dose in our cells to maintain cellular 
integrity. 
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